Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Deferred Revenue

LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Deferred Revenue of -$589.00 thousand for the 3-month period ending 2018-08-26, per its 10-Q filed 2018-10-05.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-10-05

  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2018-08-26 was -$589.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2018-05-27 was $695.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2018-02-25 was $112.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2017-11-26 was $1.39M.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2018 was $2.17M.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$522.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$11.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$411.00K, a 6950.00% decline from fiscal 2014.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2018-08-26-$589.00K
10-Q · filed 2018-10-05
$106.00K
derived: sum of 2 quarters · filed 2018-10-05
$218.00K
derived: sum of 3 quarters · filed 2018-10-05
$1.61M
derived: sum of 4 quarters · filed 2018-10-05
2018-05-27$695.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$807.00K
derived: sum of 2 quarters · filed 2018-08-09
$2.20M
derived: sum of 3 quarters · filed 2018-08-09
$2.17M
10-K · filed 2018-08-09
2018-02-25$112.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
$1.50M
derived: sum of 2 quarters · filed 2018-04-05
$1.48M
10-Q · filed 2018-04-05
$1.36M
derived: sum of 4 quarters · filed 2018-10-05
2017-11-26$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$1.36M
10-Q · filed 2018-01-05
$1.24M
derived: sum of 3 quarters · filed 2018-10-05
$1.20M
derived: sum of 4 quarters · filed 2018-10-05
2017-08-27-$26.00K
10-Q · filed 2018-10-05
-$145.00K
derived: sum of 2 quarters · filed 2018-10-05
-$190.00K
derived: sum of 3 quarters · filed 2018-10-05
-$422.00K
derived: sum of 4 quarters · filed 2018-10-05
2017-05-28-$119.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
-$164.00K
derived: sum of 2 quarters · filed 2018-08-09
-$396.00K
derived: sum of 3 quarters · filed 2018-08-09
-$522.00K
10-K · filed 2018-08-09
2017-02-26-$45.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
-$277.00K
derived: sum of 2 quarters · filed 2018-04-05
-$403.00K
10-Q · filed 2018-04-05
-$723.00K
derived: sum of 4 quarters · filed 2018-08-09
2016-11-27-$232.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
-$358.00K
10-Q · filed 2018-01-05
-$678.00K
derived: sum of 3 quarters · filed 2018-08-09
$93.00K
derived: sum of 4 quarters · filed 2018-08-09
2016-08-28-$126.00K
10-Q · filed 2017-09-28
-$446.00K
derived: sum of 2 quarters · filed 2018-08-09
$325.00K
derived: sum of 3 quarters · filed 2018-08-09
-$148.00K
derived: sum of 4 quarters · filed 2018-08-09
2016-05-29-$320.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$451.00K
derived: sum of 2 quarters · filed 2018-08-09
-$22.00K
derived: sum of 3 quarters · filed 2018-08-09
-$11.00K
10-K · filed 2018-08-09
2016-02-28$771.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07
$298.00K
derived: sum of 2 quarters · filed 2017-04-07
$309.00K
10-Q · filed 2017-04-07
$50.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-11-29-$473.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05
-$462.00K
10-Q · filed 2017-01-05
-$721.00K
derived: sum of 3 quarters · filed 2018-03-15
$170.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-08-30$11.00K
10-Q · filed 2016-09-29
-$248.00K
derived: sum of 2 quarters · filed 2018-03-15
$643.00K
derived: sum of 3 quarters · filed 2018-03-15
-$205.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-05-31-$259.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15
$632.00K
derived: sum of 2 quarters · filed 2018-03-15
-$216.00K
derived: sum of 3 quarters · filed 2018-03-15
-$411.00K
10-K/A · filed 2018-03-15
2015-03-01$891.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30
$43.00K
derived: sum of 2 quarters · filed 2016-03-30
-$152.00K
10-Q · filed 2016-03-30
-$572.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30-$848.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07
-$1.04M
10-Q · filed 2016-01-07
-$1.46M
derived: sum of 3 quarters · filed 2016-08-01
-$1.07M
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31-$195.00K
10-Q · filed 2015-10-01
-$615.00K
derived: sum of 2 quarters · filed 2016-08-01
-$223.00K
derived: sum of 3 quarters · filed 2016-08-01
$431.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-05-25-$420.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
-$28.00K
derived: sum of 2 quarters · filed 2016-08-01
$626.00K
derived: sum of 3 quarters · filed 2016-08-01
$6.00K
10-K · filed 2016-08-01
2014-02-23$392.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02
$1.05M
derived: sum of 2 quarters · filed 2015-04-02
$426.00K
10-Q · filed 2015-04-02
-$71.00K
derived: sum of 4 quarters · filed 2015-07-31
2013-11-24$654.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09
$34.00K
10-Q · filed 2015-01-09
-$463.00K
derived: sum of 3 quarters · filed 2015-07-31
$212.00K
derived: sum of 4 quarters · filed 2015-07-31
2013-08-25-$620.00K
10-Q · filed 2014-10-08
-$1.12M
derived: sum of 2 quarters · filed 2015-07-31
-$442.00K
derived: sum of 3 quarters · filed 2015-07-31
$102.00K
derived: sum of 4 quarters · filed 2015-07-31
2013-05-26-$497.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31
$178.00K
derived: sum of 2 quarters · filed 2015-07-31
$722.00K
derived: sum of 3 quarters · filed 2015-07-31
$1.09M
10-K · filed 2015-07-31
2013-02-24$675.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28
$1.22M
derived: sum of 2 quarters · filed 2014-03-28
$1.58M
10-Q · filed 2014-03-28
$1.40M
derived: sum of 4 quarters · filed 2014-08-01
2012-11-25$544.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03
$908.00K
10-Q · filed 2014-01-03
$726.00K
derived: sum of 3 quarters · filed 2014-08-01
$715.00K
derived: sum of 4 quarters · filed 2014-08-01
2012-08-26$364.00K
10-Q · filed 2013-09-26
$182.00K
derived: sum of 2 quarters · filed 2014-08-01
$171.00K
derived: sum of 3 quarters · filed 2014-08-01
-$624.00K
derived: sum of 4 quarters · filed 2014-08-01
2012-05-27-$182.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
-$193.00K
derived: sum of 2 quarters · filed 2014-08-01
-$988.00K
derived: sum of 3 quarters · filed 2014-08-01
-$2.50M
10-K · filed 2014-08-01
2012-02-26-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04
-$806.00K
derived: sum of 2 quarters · filed 2013-04-04
-$2.31M
10-Q · filed 2013-04-04
-$3.62M
derived: sum of 4 quarters · filed 2013-08-07
2011-11-27-$795.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04
-$2.30M
10-Q · filed 2013-01-04
-$3.61M
derived: sum of 3 quarters · filed 2013-08-07
2011-08-28-$1.51M
10-Q/A · filed 2013-01-02
-$2.82M
derived: sum of 2 quarters · filed 2013-08-07
2011-05-29-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07
-$1.73M
10-K · filed 2013-08-07
2011-02-27-$425.00K
10-Q · filed 2012-03-28
2010-11-28-$2.15M
10-Q · filed 2012-01-05
2010-08-29-$1.19M
10-Q · filed 2011-10-05
2010-05-30-$2.04M
10-K · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B